Concepedia

Tycel Phillips

TP

75

Publications

3.4K

Citations

31

H-Index

1971

Active since

Affiliations

University of Michigan(Current)

The University of Texas MD Anderson Cancer Center

The Ohio State University

Michigan Center for Translational Pathology

City of Hope

Tycel Phillips is an author at University of Michigan specializing in medicine, immunology, and oncology.

ORCID

Top concepts

Publications per year

1971–2024

75

Publications

75

Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

Catherine Thiéblemont, Tycel Phillips, Hervé Ghesquières et al. · Journal of Clinical Oncology · 2022 · 484 citations · Full text

Postibrutinib outcomes in patients with mantle cell lymphoma

Peter Martin, Kami J. Maddocks, John P. Leonard et al. · Blood · 2016 · 275 citations · Full text

Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial

Asra Ahmed, Samuel A. Merrill, Fares Alsawah et al. · The Lancet Haematology · 2019 · 250 citations · Full text

, , +4

Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma

Nathan Fowler, Felipe Samaniego, Wojciech Jurczak et al. · Journal of Clinical Oncology · 2021 · 151 citations · Full text

Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers

Andrew M. Evens, Alexey V. Danilov, Deepa Jagadeesh et al. · Blood · 2021 · 122 citations · Full text

Rows per page

1–5 of 75